Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
AT-406 (SM-406): Structural Insights and Next-Gen Apoptosis
2026-04-30
Explore the advanced structural mechanisms underlying AT-406 (SM-406) action—a potent apoptosis inducer—through the latest protein complex discoveries. This article uniquely bridges atomic-level death receptor signaling with practical cancer assay optimization.
-
High Fluid Viscosity Drives P-gp–Mediated Chemoresistance in
2026-04-30
This study reveals that elevated extracellular fluid viscosity in tumors induces chemoresistance by upregulating P-glycoprotein (P-gp) via a mechanotransduction pathway. The findings highlight how mechanical microenvironmental cues, specifically viscosity, can modulate cellular drug resistance and suggest new avenues for overcoming chemoresistance in cancer therapy.
-
SB 431542: Optimizing ALK5 Inhibitor Workflows in Cell Biolo
2026-04-29
SB 431542 stands out as a highly selective ALK5 inhibitor, enabling precise dissection of TGF-β signaling in regenerative and cancer research. This article translates cutting-edge reference findings into actionable protocols, troubleshooting, and advanced applications for maximizing reproducibility and biological insight.
-
BFH772 (VEGFR2 inhibitor): Technical Guidance and Protocols
2026-04-29
BFH772 is a highly selective VEGFR2 inhibitor designed for researchers studying VEGFR2-mediated angiogenesis, particularly in tumor model systems. It is best suited for workflows requiring high kinase selectivity and organic solvent compatibility, but is not recommended for assays demanding water solubility or broad-spectrum kinase inhibition.
-
SB 431542: ALK5 Inhibitor Workflows for Advanced TGF-β Resea
2026-04-28
SB 431542 stands out as an ALK5 inhibitor for precise TGF-β pathway manipulation, supporting organoid, cancer, and immunology models. This guide translates recent innovations and troubleshooting strategies into actionable, reproducible protocols for cutting-edge experimental design.
-
Gamma-linolenic Acid: Optimizing Anti-Inflammatory Workflows
2026-04-28
Gamma-linolenic acid (GLA) empowers anti-inflammatory research with its unique LTB4 receptor antagonism and robust antioxidant properties. Discover how APExBIO’s high-purity GLA drives reproducible assays, delivers reliable results in lipid metabolism and apoptosis studies, and resolves common workflow challenges.
-
Remdesivir (GS-5734): Structural Basis for Targeting Viral R
2026-04-27
Discover how Remdesivir (GS-5734) exploits viral RNA polymerase structures to achieve potent, broad-spectrum antiviral activity. This article uniquely bridges molecular insights and practical assay design, offering new depth for coronavirus and Ebola virus research.
-
Pharmacological SMYD2 Inhibition Mitigates Cisplatin-Induced
2026-04-27
Chen et al. provide direct evidence that pharmacological inhibition of SMYD2, using agents such as AZ505, ameliorates cisplatin-induced renal fibrosis and inflammation in mouse models and cell cultures. Their findings clarify the mechanistic role of SMYD2 in chronic kidney disease progression and highlight a promising epigenetic target for future renal fibrosis interventions.
-
Deep Learning Reveals Cardiotoxicity in iPSC-CM Drug Screens
2026-04-26
This study demonstrates a scalable high-content screening approach using deep learning and human iPSC-derived cardiomyocytes to detect drug-induced cardiotoxicity. The method enables early identification of potentially harmful compounds, improving the de-risking of drug discovery pipelines.
-
Tacrine Hydrochloride Hydrate (SKU C6449): Practical Solutio
2026-04-25
This scenario-driven article addresses common laboratory challenges in neurodegenerative disease research, focusing on the use of Tacrine hydrochloride hydrate (SKU C6449) for enzyme inhibition and neuroprotection assays. By integrating evidence-backed Q&A, protocol parameters, and vendor selection guidance, it demonstrates how the compound—sourced from APExBIO—empowers reproducible, high-sensitivity workflows for Alzheimer's disease models and cholinergic pathway studies.
-
Tobramycin in Precision Microbiology: Advanced Assay Design
2026-04-24
Explore Tobramycin, a leading aminoglycoside antibiotic, through the lens of advanced assay optimization and resistance profiling. This article delivers unique comparative protocols and actionable guidance to elevate microbiology research.
-
Neomycin Sulfate: Precision Aminoglycoside for RNA/DNA Studi
2026-04-24
Neomycin sulfate stands apart as an aminoglycoside antibiotic with unique mechanistic versatility, from stabilizing DNA triplexes to modulating ion channels and disrupting viral RNA-protein complexes. This guide translates bench research and recent literature into actionable workflows and troubleshooting strategies for molecular biologists and translational researchers.
-
iRhom2 Modulates Olfactory Receptor Regulation and Adaptatio
2026-04-23
This study reveals that iRhom2, a key regulator of ADAM17, is uniquely expressed in olfactory sensory neurons and orchestrates odorant receptor gene regulation in response to environmental cues. These findings provide new insight into the molecular mechanisms of olfactory adaptation and highlight pathways that may inform future sensory biology research.
-
Probenecid (4-(dipropylsulfamoyl)benzoic acid): Protocols &
2026-04-23
Probenecid empowers researchers to reverse multidrug resistance and probe neuroprotection with precision. This guide details optimized workflows, troubleshooting insights, and unique applications across oncology and neuroscience, leveraging both classical mechanisms and new immunometabolic findings.
-
Berberine Hydrochloride: Applied Workflows for Metabolic and
2026-04-22
Berberine Hydrochloride offers multi-modal utility in metabolic, cardiovascular, and inflammation research, with proven efficacy in modulating AMPK and NLRP3 pathways. This article delivers actionable workflows, troubleshooting guidance, and evidence-based insights to empower reproducible discovery in complex disease models.